The Filings Report

Corteva, Inc. Common Stock

CTVANYSECIK 1755672Consumer Defensive / Packaged Foods & Farm Productsfiscal year ends December34 quarters since 2018

Revenue, Q2 FY2026
$6.4B
−1.2% on Q2 FY2025
Net income
$1.2B
−11.6% on Q2 FY2025
Free cash flow
−$588M
−170.9% on Q2 FY2025
Diluted EPS
$1.73
−9.9% on Q2 FY2025
Revenue, TTM
$17.8B
trailing four quarters
Net margin, TTM
5.7%
net income $1.0B
Free cash flow, TTM
$629M
$1.2B less $582M capex
Cash and equivalents
$2.4B
long-term debt —, Jun 30, 2026
Shares, 12-month change
−1.8%
667M shares, Jun 30, 2026
Buybacks, TTM
$1.1B
13.2% of market value
Dividends, TTM
$484M
6.1% of market value
Market value
$7.9B
at the close, buybacks

Latest quarter Q2 FY2026, filed July 31, 2026. Trailing figures sum the latest four quarters. Market values at the latest close, from a market data vendor.

In Q2 FY2026, the quarter ended June 30, 2026, Corteva, Inc. Common Stock reported revenue of $6.4B, −1.2% on Q2 FY2025, and net income of $1.2B (−11.6%). Free cash flow, operating cash flow less capital expenditures, was −$588M (−$466M less $122M). Diluted earnings per share were $1.73.

Share price

Daily candlesticks from November 11, 2024 to November 6, 2026, with each earnings release marked; a release after the close marks the day it came out, so its reaction is the next candle. See this earnings season for every company’s reaction.

CTVA daily priceSplit-adjusted, US dollars; an earnings release
Nov 6, 2026O $11.90 · H $12.07 · L $11.78 · C $11.90 · −1.16% on the dayOver the range: +4.94%, Nov 7, 2025 to Nov 6, 2026
$11$12$14$15$17Nov 25Jan 26Apr 26Jun 26Aug 26Nov 26

The last 16 quarters

Q3 FY2022 to Q2 FY2026, through the filing of July 31, 2026.

Revenue and net incomeRevenueNet income
−$2B$0$2B$4B$6B$8BQ3'22, Revenue: $2.8BQ3'22, Net income: −$331MQ3'22Q4'22, Revenue: $3.8BQ4'22, Net income: −$55MQ4'22Q1'23, Revenue: $4.9BQ1'23, Net income: $595MQ1'23Q2'23, Revenue: $6.0BQ2'23, Net income: $714MQ2'23Q3'23, Revenue: $2.6BQ3'23, Net income: −$321MQ3'23Q4'23, Revenue: $3.7BQ4'23, Net income: −$253MQ4'23Q1'24, Revenue: $4.5BQ1'24, Net income: $419MQ1'24Q2'24, Revenue: $6.1BQ2'24, Net income: $1.1BQ2'24Q3'24, Revenue: $2.3BQ3'24, Net income: −$524MQ3'24Q4'24, Revenue: $4.0BQ4'24, Net income: −$41MQ4'24Q1'25, Revenue: $4.4BQ1'25, Net income: $652MQ1'25Q2'25, Revenue: $6.5BQ2'25, Net income: $1.3BQ2'25Q3'25, Revenue: $2.6BQ3'25, Net income: −$320MQ3'25Q4'25, Revenue: $3.9BQ4'25, Net income: −$552MQ4'25Q1'26, Revenue: $4.9BQ1'26, Net income: $720MQ1'26Q2'26, Revenue: $6.4BQ2'26, Net income: $1.2BQ2'26−$2B$0$2B$4B$6B$8BQ3'22, Revenue: $2.8BQ3'22, Net income: −$331MQ3'22Q4'22, Revenue: $3.8BQ4'22, Net income: −$55MQ4'22Q1'23, Revenue: $4.9BQ1'23, Net income: $595MQ1'23Q2'23, Revenue: $6.0BQ2'23, Net income: $714MQ2'23Q3'23, Revenue: $2.6BQ3'23, Net income: −$321MQ3'23Q4'23, Revenue: $3.7BQ4'23, Net income: −$253MQ4'23Q1'24, Revenue: $4.5BQ1'24, Net income: $419MQ1'24Q2'24, Revenue: $6.1BQ2'24, Net income: $1.1BQ2'24Q3'24, Revenue: $2.3BQ3'24, Net income: −$524MQ3'24Q4'24, Revenue: $4.0BQ4'24, Net income: −$41MQ4'24Q1'25, Revenue: $4.4BQ1'25, Net income: $652MQ1'25Q2'25, Revenue: $6.5BQ2'25, Net income: $1.3BQ2'25Q3'25, Revenue: $2.6BQ3'25, Net income: −$320MQ3'25Q4'25, Revenue: $3.9BQ4'25, Net income: −$552MQ4'25Q1'26, Revenue: $4.9BQ1'26, Net income: $720MQ1'26Q2'26, Revenue: $6.4BQ2'26, Net income: $1.2BQ2'26−$2B$0$2B$4B$6B$8BQ3'22, Revenue: $2.8BQ3'22, Net income: −$331MQ4'22, Revenue: $3.8BQ4'22, Net income: −$55MQ4'22Q1'23, Revenue: $4.9BQ1'23, Net income: $595MQ2'23, Revenue: $6.0BQ2'23, Net income: $714MQ2'23Q3'23, Revenue: $2.6BQ3'23, Net income: −$321MQ4'23, Revenue: $3.7BQ4'23, Net income: −$253MQ4'23Q1'24, Revenue: $4.5BQ1'24, Net income: $419MQ2'24, Revenue: $6.1BQ2'24, Net income: $1.1BQ2'24Q3'24, Revenue: $2.3BQ3'24, Net income: −$524MQ4'24, Revenue: $4.0BQ4'24, Net income: −$41MQ4'24Q1'25, Revenue: $4.4BQ1'25, Net income: $652MQ2'25, Revenue: $6.5BQ2'25, Net income: $1.3BQ2'25Q3'25, Revenue: $2.6BQ3'25, Net income: −$320MQ4'25, Revenue: $3.9BQ4'25, Net income: −$552MQ4'25Q1'26, Revenue: $4.9BQ1'26, Net income: $720MQ2'26, Revenue: $6.4BQ2'26, Net income: $1.2BQ2'26

Net income losses drawn in red.

Free cash flow
−$4B−$2B$0$2B$4B$6BQ3'22, Free cash flow: −$667MQ3'22Q4'22, Free cash flow: $2.9BQ4'22Q1'23, Free cash flow: −$3.5BQ1'23Q2'23, Free cash flow: $713MQ2'23Q3'23, Free cash flow: −$267MQ3'23Q4'23, Free cash flow: $4.2BQ4'23Q1'24, Free cash flow: −$2.8BQ1'24Q2'24, Free cash flow: $337MQ2'24Q3'24, Free cash flow: −$24MQ3'24Q4'24, Free cash flow: $4.0BQ4'24Q1'25, Free cash flow: −$2.2BQ1'25Q2'25, Free cash flow: $829MQ2'25Q3'25, Free cash flow: $36MQ3'25Q4'25, Free cash flow: $4.2BQ4'25Q1'26, Free cash flow: −$3.0BQ1'26Q2'26, Free cash flow: −$588MQ2'26−$4B−$2B$0$2B$4B$6BQ3'22, Free cash flow: −$667MQ3'22Q4'22, Free cash flow: $2.9BQ4'22Q1'23, Free cash flow: −$3.5BQ1'23Q2'23, Free cash flow: $713MQ2'23Q3'23, Free cash flow: −$267MQ3'23Q4'23, Free cash flow: $4.2BQ4'23Q1'24, Free cash flow: −$2.8BQ1'24Q2'24, Free cash flow: $337MQ2'24Q3'24, Free cash flow: −$24MQ3'24Q4'24, Free cash flow: $4.0BQ4'24Q1'25, Free cash flow: −$2.2BQ1'25Q2'25, Free cash flow: $829MQ2'25Q3'25, Free cash flow: $36MQ3'25Q4'25, Free cash flow: $4.2BQ4'25Q1'26, Free cash flow: −$3.0BQ1'26Q2'26, Free cash flow: −$588MQ2'26−$4B−$2B$0$2B$4B$6BQ3'22, Free cash flow: −$667MQ4'22, Free cash flow: $2.9BQ4'22Q1'23, Free cash flow: −$3.5BQ2'23, Free cash flow: $713MQ2'23Q3'23, Free cash flow: −$267MQ4'23, Free cash flow: $4.2BQ4'23Q1'24, Free cash flow: −$2.8BQ2'24, Free cash flow: $337MQ2'24Q3'24, Free cash flow: −$24MQ4'24, Free cash flow: $4.0BQ4'24Q1'25, Free cash flow: −$2.2BQ2'25, Free cash flow: $829MQ2'25Q3'25, Free cash flow: $36MQ4'25, Free cash flow: $4.2BQ4'25Q1'26, Free cash flow: −$3.0BQ2'26, Free cash flow: −$588MQ2'26

Operating cash flow less capital expenditures; negative quarters in red.

Cash and equivalents against long-term debtCash and equivalentsLong-term debt
$0$2B$4B$6BQ3'22, Cash and equivalents: $2.2BQ3'22Q4'22, Cash and equivalents: $3.2BQ4'22Q1'23, Cash and equivalents: $1.6BQ1'23Q2'23, Cash and equivalents: $2.6BQ2'23Q3'23, Cash and equivalents: $2.3BQ3'23Q4'23, Cash and equivalents: $2.6BQ4'23Q1'24, Cash and equivalents: $1.5BQ1'24Q2'24, Cash and equivalents: $1.8BQ2'24Q3'24, Cash and equivalents: $2.4BQ3'24Q4'24, Cash and equivalents: $3.1BQ4'24Q1'25, Cash and equivalents: $2.0BQ1'25Q2'25, Cash and equivalents: $2.1BQ2'25Q3'25, Cash and equivalents: $2.5BQ3'25Q4'25, Cash and equivalents: $4.5BQ4'25Q1'26, Cash and equivalents: $2.0BQ1'26Q2'26, Cash and equivalents: $2.4BQ2'26$0$2B$4B$6BQ3'22, Cash and equivalents: $2.2BQ3'22Q4'22, Cash and equivalents: $3.2BQ4'22Q1'23, Cash and equivalents: $1.6BQ1'23Q2'23, Cash and equivalents: $2.6BQ2'23Q3'23, Cash and equivalents: $2.3BQ3'23Q4'23, Cash and equivalents: $2.6BQ4'23Q1'24, Cash and equivalents: $1.5BQ1'24Q2'24, Cash and equivalents: $1.8BQ2'24Q3'24, Cash and equivalents: $2.4BQ3'24Q4'24, Cash and equivalents: $3.1BQ4'24Q1'25, Cash and equivalents: $2.0BQ1'25Q2'25, Cash and equivalents: $2.1BQ2'25Q3'25, Cash and equivalents: $2.5BQ3'25Q4'25, Cash and equivalents: $4.5BQ4'25Q1'26, Cash and equivalents: $2.0BQ1'26Q2'26, Cash and equivalents: $2.4BQ2'26$0$2B$4B$6BQ3'22, Cash and equivalents: $2.2BQ4'22, Cash and equivalents: $3.2BQ4'22Q1'23, Cash and equivalents: $1.6BQ2'23, Cash and equivalents: $2.6BQ2'23Q3'23, Cash and equivalents: $2.3BQ4'23, Cash and equivalents: $2.6BQ4'23Q1'24, Cash and equivalents: $1.5BQ2'24, Cash and equivalents: $1.8BQ2'24Q3'24, Cash and equivalents: $2.4BQ4'24, Cash and equivalents: $3.1BQ4'24Q1'25, Cash and equivalents: $2.0BQ2'25, Cash and equivalents: $2.1BQ2'25Q3'25, Cash and equivalents: $2.5BQ4'25, Cash and equivalents: $4.5BQ4'25Q1'26, Cash and equivalents: $2.0BQ2'26, Cash and equivalents: $2.4BQ2'26

Positions at each quarter end, as filed; short-term investments are not included.

Income statement

Last eight quarters, newest first, through Q2 FY2026 filed July 31, 2026.

Corteva, Inc. Common Stock income statement, quarterly
Millions of dollarsQ2 FY2026ended Jun 30, 2026filed Jul 31, 2026Q1 FY2026ended Mar 31, 2026filed May 6, 2026Q4 FY2025ended Dec 31, 2025filed Feb 12, 2026Q3 FY2025ended Sep 30, 2025filed Nov 5, 2025Q2 FY2025ended Jun 30, 2025filed Aug 7, 2025Q1 FY2025ended Mar 31, 2025filed May 8, 2025Q4 FY2024ended Dec 31, 2024filed Feb 14, 2025Q3 FY2024ended Sep 30, 2024filed Nov 7, 2024YoYQ2 FY2026vs Q2 FY2025
Revenue6,3794,9053,9102,6186,4564,4173,9782,326−1.2%
Cost of revenue2,7182,3722,2541,6442,9322,3422,4961,565−7.3%
Gross profit—————————
Research and development388341413351375335365348+3.5%
Selling, general and administrative1,1648778607251,156751735671+0.7%
Operating income—————————
Other income (expense)(115)(117)(665)(23)1031519(107)−211.7%
Pretax income1,625858(530)(370)1,80478488(633)−9.9%
Income tax4081337(62)422117138(114)−3.3%
Net income1,161720(552)(320)1,314652(41)(524)−11.6%
Diluted EPS ($)1.731.07—(0.47)1.920.95—(0.76)−9.9%
Diluted shares (millions)670674—679683687—691—

Fourth quarters are the fiscal year less the first nine months when the filer reports no discrete fourth quarter, and are marked. Diluted EPS is never derived, so a derived quarter shows none. Italic figures are derived.

Balance sheet

Last eight quarters, newest first, through Q2 FY2026 filed July 31, 2026.

Corteva, Inc. Common Stock balance sheet, quarterly
Millions of dollarsQ2 FY2026ended Jun 30, 2026filed Jul 31, 2026Q1 FY2026ended Mar 31, 2026filed May 6, 2026Q4 FY2025ended Dec 31, 2025filed Feb 12, 2026Q3 FY2025ended Sep 30, 2025filed Nov 5, 2025Q2 FY2025ended Jun 30, 2025filed Aug 7, 2025Q1 FY2025ended Mar 31, 2025filed May 8, 2025Q4 FY2024ended Dec 31, 2024filed Feb 14, 2025Q3 FY2024ended Sep 30, 2024filed Nov 7, 2024YoYQ2 FY2026vs Q2 FY2025
Cash and equivalents2,3651,9644,5212,5092,0652,0083,1062,421+14.5%
Short-term investments029777616372−100.0%
Total current assets16,35717,38517,33516,43816,00416,58715,09715,649+2.2%
Total assets41,64242,71742,84542,19841,75942,12340,82541,908−0.3%
Total current liabilities10,78911,85412,12510,4209,51611,48110,38610,424+13.4%
Long-term debt—————————
Total liabilities—————————
Stockholders’ equity25,15924,36224,14425,21925,90924,28523,78924,737−2.9%
Shares outstanding (millions)667669673676679682686687—

Positions at each period end. Nothing on this statement is derived. Long-term debt is the filed noncurrent line only; no total-debt composite is constructed across filers. Italic figures are derived.

Cash flow statement

Last eight quarters, newest first, through Q2 FY2026 filed July 31, 2026.

Corteva, Inc. Common Stock cash flow statement, quarterly
Millions of dollarsQ2 FY2026ended Jun 30, 2026filed Jul 31, 2026Q1 FY2026ended Mar 31, 2026filed May 6, 2026Q4 FY2025ended Dec 31, 2025filed Feb 12, 2026Q3 FY2025ended Sep 30, 2025filed Nov 5, 2025Q2 FY2025ended Jun 30, 2025filed Aug 7, 2025Q1 FY2025ended Mar 31, 2025filed May 8, 2025Q4 FY2024ended Dec 31, 2024filed Feb 14, 2025Q3 FY2024ended Sep 30, 2024filed Nov 7, 2024YoYQ2 FY2026vs Q2 FY2025
Operating cash flow(466)(2,891)4,375193947(2,109)4,173130−149.2%
Capital expenditures1228122215711894181154+3.4%
Free cash flow (CFO − capex)(588)(2,972)4,15336829(2,203)3,992(24)−170.9%
Depreciation and amortization339297306300301296302306+12.6%
Share repurchases2502503012502502702522530.0%
Dividends paid120121121122116116118117+3.4%

10-Qs file cash flows as year-to-date totals, so quarterly figures are differenced from consecutive filings and marked. Free cash flow is operating cash flow less capital expenditures, computed from the two filed lines. Italic figures are derived.

Annual statements

Every fiscal year filed, newest first, through FY2025 filed February 12, 2026.

Income statement

Corteva, Inc. Common Stock income statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 12, 2026FY2024ended Dec 31, 2024filed Feb 14, 2025FY2023ended Dec 31, 2023filed Feb 8, 2024FY2022ended Dec 31, 2022filed Feb 9, 2023FY2021ended Dec 31, 2021filed Feb 10, 2022FY2020ended Dec 31, 2020filed Feb 11, 2021FY2019ended Dec 31, 2019filed Feb 14, 2020FY2018ended Dec 31, 2018filed May 31, 2019
Revenue17,40116,90817,22617,45515,65514,21713,84614,287
Cost of revenue9,1729,5299,92010,4369,2208,5078,5759,948
Gross profit————————
Research and development1,4741,4021,3371,2161,1871,1421,1471,355
Selling, general and administrative3,4923,1963,1763,1733,2093,0433,0653,041
Operating income————————
Other income (expense)(570)(300)(448)(60)1,348212215249
Pretax income1,6881,2751,0931,4262,346675(316)(6,806)
Income tax484412152210524(81)(46)(31)
Net income1,0949077351,1471,759681(959)(5,065)
Diluted EPS ($)1.601.301.031.582.370.91(1.28)(6.76)
Diluted shares (millions)681696712725742751750749

Balance sheet

Corteva, Inc. Common Stock balance sheet, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 12, 2026FY2024ended Dec 31, 2024filed Feb 14, 2025FY2023ended Dec 31, 2023filed Feb 8, 2024FY2022ended Dec 31, 2022filed Feb 9, 2023FY2021ended Dec 31, 2021filed Feb 10, 2022FY2020ended Dec 31, 2020filed Feb 11, 2021FY2019ended Dec 31, 2019filed Feb 14, 2020FY2018ended Dec 31, 2018filed May 31, 2019
Cash and equivalents4,5213,1062,6443,1914,4593,5261,7642,270
Short-term investments963981248626955
Total current assets17,33515,09716,26016,79515,54614,76813,51922,972
Total assets42,84540,82542,99642,61842,34442,64942,397108,683
Total current liabilities12,12510,38610,40910,7449,5588,5488,23813,310
Long-term debt————————
Total liabilities————————
Stockholders’ equity24,14423,78925,03725,30225,38424,82424,30974,660
Shares outstanding (millions)673686702713727744749—

Cash flow statement

Corteva, Inc. Common Stock cash flow statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 12, 2026FY2024ended Dec 31, 2024filed Feb 14, 2025FY2023ended Dec 31, 2023filed Feb 8, 2024FY2022ended Dec 31, 2022filed Feb 9, 2023FY2021ended Dec 31, 2021filed Feb 10, 2022FY2020ended Dec 31, 2020filed Feb 11, 2021FY2019ended Dec 31, 2019filed Feb 14, 2020FY2018ended Dec 31, 2018filed May 31, 2019
Operating cash flow3,4062,1451,7698722,7272,0641,070483
Capital expenditures5915975956055734751,1631,501
Free cash flow (CFO − capex)2,8151,5481,1742672,1541,589(93)(1,018)
Depreciation and amortization1,2031,2271,2111,2231,2431,1771,5992,790
Share repurchases1,0711,0097561,000950275250
Dividends paid475458439418397(388)(194)0

Insider activity

Form 4 filings by officers, directors and 10% owners, November 9, 2024 to November 9, 2026. Only open-market purchases and sales count as buys and sells; awards, exercises, tax withholding and gifts are listed in grey and never counted.

Bought, three months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, three months
$0
0 sales by 0 insiders; officers and directors $0
Bought, twelve months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, twelve months
$0
2 sales by 1 insider; officers and directors $0

The last 25 transactions

TradedInsiderRoleTransactionSharesPriceValueHeld afterFiled
Oct 30, 2026Policinski Christopher J.Directoraward2,792$11.64$33K5,566Nov 3, 2026
Oct 30, 2026Nayyar Nayaki RDirectoraward2,792$11.64$33K39,625Nov 3, 2026
Oct 30, 2026Giesselman Janet PlautDirectoraward666$11.64$8K20,956Nov 3, 2026
Oct 1, 2026Titus BrianSee Remarksother13,315$0.00—23,379Oct 5, 2026
Oct 1, 2026Titus BrianSee Remarksother11,083$0.00—34,462Oct 5, 2026
Oct 1, 2026Kissam Luther C IVChief Executive Officerother127,949$0.00—153,087Oct 5, 2026
Sep 16, 2026Johnson David PaulEVP, Chief Financial Officertax withholding8,517$81.01$690K73,626Sep 17, 2026
Sep 15, 2026Johnson Jennifer AmySVP, Chief Legal Officertax withholding446$83.39$37K16,849Sep 17, 2026
Jul 31, 2026Policinski Christopher J.Directoraward413$78.71$33K2,768Aug 4, 2026
Jul 31, 2026Nayyar Nayaki RDirectoraward413$78.71$33K36,754Aug 4, 2026
Jul 31, 2026Giesselman Janet PlautDirectoraward98$78.71$8K20,248Aug 4, 2026
Jun 1, 2026Kissam Luther C IVCEO, Crop Protection Businessaward24,138$0.00—25,138Jun 3, 2026
Apr 30, 2026Nayyar Nayaki RDirectoraward401$81.01$33K36,255May 4, 2026
Apr 30, 2026Lutz Marcos MDirectortax withholding906$81.01$73K63,053May 4, 2026
Apr 30, 2026Giesselman Janet PlautDirectoraward96$81.01$8K20,103May 4, 2026
Apr 30, 2026Engel Klaus ADirectortax withholding906$81.01$73K40,219May 4, 2026
Apr 28, 2026Everitt David CDirectoraward2,350$0.00—19,738Apr 30, 2026
Apr 28, 2026Ward PatDirectoraward2,350$0.00—38,432Apr 30, 2026
Apr 28, 2026Preete Kerry JDirectoraward2,350$0.00—18,467Apr 30, 2026
Apr 28, 2026Policinski Christopher J.Directoraward2,350$0.00—2,350Apr 30, 2026
Apr 28, 2026Nayyar Nayaki RDirectoraward2,350$0.00—35,853Apr 30, 2026
Apr 28, 2026Lutz Marcos MDirectoraward2,350$0.00—63,959Apr 30, 2026
Apr 28, 2026Grimes Karen H.Directoraward2,350$0.00—18,272Apr 30, 2026
Apr 28, 2026Giesselman Janet PlautDirectoraward2,350$0.00—20,007Apr 30, 2026
Apr 28, 2026Gilson Jean-MarcDirectoraward2,350$0.00—2,350Apr 30, 2026

Full insider history for Corteva, Inc. Common Stock, or insider activity across all companies. A record of filings, not a recommendation.

Sources

Fiscal year ends in month 12; periods are labeled with the issuer's own fiscal calendar. Values are as most recently filed (restatements apply; per-share values are on current split basis per the connector's split table, flagged in adjusted). Flow items flagged in `derived` were computed (Q4 = FY − nine months; quarterly cash flow differenced from year-to-date filings) rather than read from a filing. `reconciliation.repaired` lists periods where a full-year figure was filed in a quarter slot: that row was dropped and the quarter rebuilt from the annual figure. `reconciliation.quarantined` lists periods where four filed quarters do not sum to the filed year — those quarterly values are withheld, so a blank there is a withholding rather than an absence of reporting.

Filer
Corteva, Inc., CIK 1755672 on EDGAR
Extract generated
November 8, 2026
Withheld
1 line-years whose four quarters do not sum to the filed year: pretax income FY2022
Repaired
none
XBRL concepts behind each line

Income statement

Revenue: Revenues
Cost of revenue: CostOfGoodsAndServicesSold
Gross profit: not filed
Research and development: ResearchAndDevelopmentExpense
Selling, general and administrative: SellingGeneralAndAdministrativeExpense
Operating income: not filed
Other income (expense): NonoperatingIncomeExpense
Pretax income: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Income tax: IncomeTaxExpenseBenefit
Net income: NetIncomeLoss
Diluted EPS ($): EarningsPerShareDiluted
Diluted shares (millions): WeightedAverageNumberOfDilutedSharesOutstanding

Balance sheet

Cash and equivalents: CashAndCashEquivalentsAtCarryingValue
Short-term investments: ShortTermInvestments
Total current assets: AssetsCurrent
Total assets: Assets
Total current liabilities: LiabilitiesCurrent
Long-term debt: not filed
Total liabilities: not filed
Stockholders’ equity: StockholdersEquity
Shares outstanding (millions): dei:EntityCommonStockSharesOutstanding

Cash flow statement

Operating cash flow: NetCashProvidedByUsedInOperatingActivities
Capital expenditures: PaymentsToAcquireProductiveAssets, PaymentsToAcquirePropertyPlantAndEquipment
Free cash flow (CFO − capex): not filed
Depreciation and amortization: DepreciationDepletionAndAmortization
Share repurchases: PaymentsForRepurchaseOfCommonStock
Dividends paid: PaymentsOfDividends

The data

The statements on this page as files, generated November 8, 2026.

JSON file
/data/financials/CTVA.json